甲状腺手术后低温沐舒坦药液雾化吸入的疗效观察

目的：探讨低温沐舒坦药液进行雾化吸入对甲状腺术后出血及呼吸道并发症的疗效。方法采用临床随机对照试验方法，将208例甲状腺术后患者用随机数字表法分为观察组和对照组。每组各104例。观察组用4～8℃的低温沐舒坦药液＋地塞米松＋0.9%NS 进行超声雾化吸入，对照组用常温药液进行超声雾化吸入，观察对比两组患者术后伤口出血引流量及引流管留置时间，咽部不适、喉部水肿等呼吸道并发症，3～7天评估疗效。结果观察组术后出血、并发症的减少明显优于对照组（p＜0.05）两组比较差异有统计学意义。结论低温药液进行雾化吸入能有效减少甲状腺术后并发症的发生，提高术后的舒适度。此操作方便、安全、有效、患者容易接受，值得临床推广和应用。

Efficacy observation of liquid Mucosolvan microtherm atomization inhalation after Thyroid surgery

To explore the efficacy of liquid Mucosolvan cryogenic aerosol inhalation to the bleeding and respiratory complications after thyroid surgery. A total of 208 patients receiving the thyriod surgery were divided equally into observation group and control group with random number table method, The observation group used 4～8℃ low-temperature liquid Mucosolvan ＋ dexamethasone ＋ 0.9%NS in Ultrasonic atomization inhalation. The control group used normal-temperature liquid medicine in Ultrasonic atomization inhalation. Observing and comparing the hemorrhage drainage and drainage tube indwelling time, pharyngeal discomfort, laryngeal edema and other respiratory complications after surgery of patients in two groups. Evaluating after curative effection 3～7days. Postoperative bleeding, complications of the observation group were obviously less than that of the control group （p〈0.05）. There was statistically significant difference between two groups. Cryogenic liquid atomization inhalation can effectively reduce thyroid surgery complications and improve postoperative comfort. This operation is convenient, safe, effective and highly susceptible for patients. It is worth to be popularized.